ADM Reports Third Quarter 2025 Results
Third quarter earnings supported by strong business execution and advancement of self-help agenda
Robust cash flow supported by portfolio optimization and continued working capital improvement
Revised guidance for full-year 2025 based on current biofuel demand environment
Expectations of clarity on biofuel policy and global trade evolution underpin constructive outlook for 2026
Key Takeaways:
-
Third quarter earnings of
$108 million , with adjusted net earnings1 of$448 million -
Third quarter EPS2 of
$0.22 , with adjusted EPS1,2 of$0.92 -
Year-to-date cash flows provided by operating activities were
$5.8 billion , with cash flows from operations before working capital1,3 of$2.1 billion
Outlook 4 :
- Outlook based on performance throughout first nine months of 2025 and current expectations with respect to the timing of anticipated benefits from favorable biofuel policy and global trade evolution
-
Revised previously provided adjusted EPS1,2 guidance for full-year 2025 to
$3.25 -$3.50 per share from approximately$4.00 per share
“During the third quarter, we made solid progress in areas within our control, as we navigated a highly dynamic global environment. We advanced our portfolio optimization initiatives, accomplished cost savings through targeted streamlining, efficiently ran our plants, and generated robust cash flow,” said Chair of the Board and CEO
“In AS&O, we achieved several volume records and sharpened our inventory management, both contributing to our overall cash flow. In Carbohydrate Solutions, we delivered another sequentially steady quarter, with uplift from improved ethanol margins. In Nutrition, we achieved sequential growth in operating profit, with record revenue achieved in
Looking forward, we expect biofuel policy clarity and trade policy evolution to provide demand signals for our industry. However, based on the environment since our last earnings call, we are revising our 2025 full-year expectations primarily to reflect lower crush margins. We are a company built to endure cycles, and our asset network, combined with our skilled workforce, will remain a source of reliable strength for our farmers, customers, partners and investors.”
|
_____________________________ |
|
1 Non-GAAP financial measures; see pages 7-8 and 14-17 for explanations and reconciliations. |
|
2 All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis. |
|
3 Cash flows from operations before working capital is a Non-GAAP financial measure and is cash flows provided by operating activities of |
|
4 Forecasted GAAP Earnings Reconciliation: |
Third Quarter and Year-To-Date 2025 Results
|
3Q 2025 Results Overview |
||||
|
($ in millions except per share amounts) |
||||
|
|
|
GAAP Measures |
||
|
|
|
Earnings Before Income Taxes |
|
EPS2 (as reported) |
|
3Q 2025 |
|
|
|
|
|
Percent change vs. 3Q 2024 |
|
36% |
|
NM3 |
|
|
|
Non-GAAP Measures |
||
|
|
|
Total Segment Operating Profit1 |
|
Adjusted EPS1,2 |
|
3Q 2025 |
|
|
|
|
|
Percent change vs. 3Q 2024 |
|
(19)% |
|
(16)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
YTD 2025 Results Overview |
|
|
|
|
|
($ in millions except per share amounts) |
|
|
|
|
|
|
|
GAAP Measures |
||
|
|
|
Earnings Before Income Taxes |
|
EPS2 (as reported) |
|
YTD 2025 |
|
|
|
|
|
Percent change vs. YTD 2024 |
|
(51)% |
|
(48)% |
|
|
|
Non-GAAP Measures |
||
|
|
|
Total Segment Operating Profit1 |
|
Adjusted EPS1,2 |
|
YTD 2025 |
|
|
|
|
|
Percent change vs. YTD 2024 |
|
(23)% |
|
(29)% |
|
1 Non-GAAP financial measures; see pages 7-8 and 14-17 for explanations and reconciliations. |
|
2 All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis. |
|
3 NM: Not Meaningful. Percentage increases above 200% or when one period includes income and other period includes loss are considered not meaningful. In 3Q24, earnings before income taxes were |
Summary of Third Quarter 2025 and Year-to-Date
For the third quarter ended
Total segment operating profit1 was
Earnings before income taxes were
|
Q3 2025 Segment Overview |
|
|
|
|
($ in millions) |
3Q 2025 |
3Q 2024 |
% Change |
|
Total Segment Operating Profit1 |
|
|
(19)% |
|
Segment Operating Profit: |
|
|
|
|
Ag Services & Oilseeds |
379 |
480 |
(21)% |
|
Carbohydrate Solutions |
336 |
452 |
(26)% |
|
Nutrition |
130 |
105 |
24% |
|
|
|
|
|
|
|
|
|
|
|
YTD 2025 Segment Overview |
|
|
|
|
($ in millions) |
YTD 2025 |
YTD 2024 |
% Change |
|
Total Segment Operating Profit1 |
|
|
(23)% |
|
Segment Operating Profit: |
|
|
|
|
Ag Services & Oilseeds |
1,170 |
1,803 |
(35)% |
|
Carbohydrate Solutions |
912 |
1,057 |
(14)% |
|
Nutrition |
340 |
298 |
14% |
|
|
|
|
|
|
1 Non-GAAP financial measures; see pages 7-8 and 14-17 for explanations and reconciliations. 2 All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis. |
|||
Agriculture Services and Oilseeds Summary (AS&O)
AS&O segment operating profit was
Ag Services subsegment operating profit was 78% higher versus the prior year quarter, driven primarily by higher export activity in
Crushing subsegment operating profit was 93% lower versus the prior year quarter, driven by lower margins as a result of muted demand due to the deferral of
Refined Products and Other subsegment operating profit was 3% lower versus the prior year quarter, primarily due to biodiesel and refining margins being negatively impacted by deferred biofuel policy, which has restrained North American demand. There were approximately
Equity earnings from the company’s investment in Wilmar were approximately 10% lower versus the prior year quarter and exclude the
|
3Q 2025 AS&O Overview |
|
|
|
|
($ in millions) |
3Q 2025 |
3Q 2024 |
% Change |
|
Segment Operating Profit |
|
|
(21)% |
|
Ag Services |
190 |
107 |
78% |
|
Crushing |
13 |
187 |
(93)% |
|
Refined Products and Other |
120 |
124 |
(3)% |
|
Wilmar |
56 |
62 |
(10)% |
|
|
|
|
|
|
|
|
|
|
|
YTD 2025 AS&O Overview |
|
|
|
|
($ in millions) |
YTD 2025 |
YTD 2024 |
% Change |
|
Segment Operating Profit |
|
|
(35)% |
|
Ag Services |
462 |
461 |
—% |
|
Crushing |
93 |
632 |
(85)% |
|
Refined Products and Other |
410 |
431 |
(5)% |
|
Wilmar |
205 |
279 |
(27)% |
Carbohydrate Solutions Summary
Carbohydrate Solutions segment operating profit was
Starches and Sweeteners (S&S) subsegment operating profit decreased by 36% versus the prior year quarter, primarily due to lower global S&S demand, which impacted both volumes and margins. S&S margins continued to be impacted by persisting higher corn costs in EMEA related to corn quality issues. Global wheat milling margins and volumes were fairly stable relative to the prior year quarter. Additionally, the prior year quarter benefited from
|
3Q 2025 Carbohydrate Solutions Overview |
|||
|
($ in millions) |
3Q 2025 |
3Q 2024 |
% Change1 |
|
Segment Operating Profit |
|
|
(26)% |
|
Starches and Sweeteners |
293 |
455 |
(36)% |
|
|
43 |
(3) |
NM |
|
|
|
|
|
|
|
|
|
|
|
YTD 2025 Carbohydrate Solutions Overview |
|
|
|
|
($ in millions) |
YTD 2025 |
YTD 2024 |
% Change1 |
|
Segment Operating Profit |
|
|
(14)% |
|
Starches and Sweeteners |
804 |
1,039 |
(23)% |
|
|
108 |
18 |
NM |
|
|
|
|
|
|
1 NM: Not Meaningful. Percentage increases above 200% or when one period includes income and other period includes loss are considered not meaningful |
|||
Nutrition Summary
Nutrition segment operating profit was
Human Nutrition subsegment operating profit was 12% higher versus the prior year quarter. In Flavors, operating profit increased, driven largely by higher margins, primarily in
Animal Nutrition subsegment operating profit was up 79% versus the prior year quarter, driven by improved margins as a result of focusing on higher-margin product lines and on-going portfolio streamlining and cost optimization efforts.
|
3Q 2025 Nutrition Overview |
|
|
|
|
($ in millions) |
3Q 2025 |
3Q 2024 |
% Change1 |
|
Segment Operating Profit |
|
|
24% |
|
Human Nutrition |
96 |
86 |
12% |
|
Animal Nutrition |
34 |
19 |
79% |
|
|
|
|
|
|
|
|
|
|
|
YTD 2025 Nutrition Overview |
|
|
|
|
($ in millions) |
YTD 2025 |
YTD 2024 |
% Change1 |
|
Segment Operating Profit |
|
|
14% |
|
Human Nutrition |
263 |
265 |
(1)% |
|
Animal Nutrition |
77 |
33 |
133% |
|
|
|
|
|
|
1 NM: Not Meaningful. Percentage increases above 200% or when one period includes income and other period includes loss are considered not meaningful |
|||
Corporate and Other Business Summary
For the third quarter of 2025, Corporate and Other Business achieved lower costs versus the prior year quarter, driven by both lower net interest expense and select corporate function costs. This excludes specified items of
Conference Call Information
About
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical or current fact included in this release, are forward-looking statements. You can identify forward-looking statements by the fact they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “outlook,” “will,” “should,” “can have,” “likely,” “forecasted,” “goals,” “guidance,” “objectives,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements the Company makes relating to its 2025 outlook as well as other future results and operations, growth opportunities, operational improvements, changes to the margin environment, future demand, policy changes, global trade clarity and pending litigation and investigations are forward-looking statements. All forward-looking statements are subject to significant risks, uncertainties and changes in circumstances that could cause actual results and outcomes to differ materially from those expressed or implied in the forward-looking statements, including, without limitation, (1) operational risks related to equipment failure, natural disasters, epidemics, pandemics, severe weather conditions, accidents, explosions, fires, cybersecurity incidents or other unexpected outages; (2) risks related to the availability and prices of agricultural commodities, agricultural commodity products, other raw materials and energy, including impacts from factors outside the Company’s control such as changes in market conditions, weather conditions, crop disease, plantings, climate change, competition and changes in global demand; (3) risks related to compliance with, and changes in, government programs, policies, laws, and regulations, including trade policies, tariffs, the
Non-GAAP Financial Measures
The Company uses certain “Non-GAAP” financial measures as defined by
Adjusted net earnings and Adjusted earnings per share (EPS). Adjusted net earnings reflects ADM’s reported net earnings after removal of the effect on net earnings of specified items as more fully described in the reconciliation tables below. Adjusted EPS reflects ADM’s diluted EPS after removal of the effect on EPS as reported of specified items as more fully described in the reconciliation tables below. Management believes that Adjusted net earnings and Adjusted EPS are useful measures of ADM’s performance because they provide investors additional information about ADM’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. These non-GAAP financial measures are not intended to replace or be alternatives to net earnings and EPS as reported, the most directly comparable GAAP financial measures, or any other measures of operating results under GAAP. Earnings amounts described above have been divided by the company’s diluted shares outstanding for each respective period in order to arrive at an adjusted EPS amount for each specified item.
Total segment operating profit. Total segment operating profit is ADM’s consolidated earnings before income taxes adjusted for Other Business, Corporate, and specified items as more fully described in the reconciliation tables below. Management believes that total segment operating profit is a useful measure of ADM’s performance because it provides investors information about ADM’s reportable segment performance excluding Other Business, Corporate overhead costs as well as specified items. Total segment operating profit is not a measure of consolidated operating results under GAAP and should not be considered an alternative to earnings before income taxes, the most directly comparable GAAP financial measure, or any other measure of consolidated operating results under GAAP.
Adjusted Return on
EBITDA is defined as earnings before interest on borrowings, taxes, depreciation and amortization. Adjusted EBITDA is defined as earnings before interest on borrowings, taxes, depreciation, and amortization, adjusted for specified items. The Company calculates Adjusted EBITDA by removing the impact of specified items and adding back the amounts of income tax expense, interest expense on borrowings, and depreciation and amortization to net earnings. Management believes that EBITDA and Adjusted EBITDA are useful measures of the Company’s performance because they provide investors additional information about the Company’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. EBITDA and Adjusted EBITDA are non-GAAP financial measures and are not intended to replace or be an alternative to net earnings, the most directly comparable GAAP financial measure.
Cash flows from operations before working capital is defined as cash flows from operating activities adjusted for changes in operating assets and liabilities as presented in the Company’s consolidated statement of cash flows. Management believes that cash flows from operations before working capital is a useful measure of the Company’s cash generation. Cash flows from operations before working capital is a non-GAAP financial measure and is not intended to replace or be an alternative to cash from operating activities, the most directly comparable GAAP financial measure.
Financial Tables Follow
Source: Corporate Release
Source:
|
Segment Operating Profit and Corporate Results (unaudited) |
|||||||||||||||||||
|
|
Quarter ended |
|
|
Nine months ended |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
(In millions) |
|
2025 |
|
|
2024 |
|
Change |
|
|
2025 |
|
|
2024 |
|
Change |
||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Segment Operating Profit |
|
|
|
|
|
|
|
||||||||||||
|
Ag Services and Oilseeds |
$ |
379 |
|
$ |
480 |
|
$ |
(101 |
) |
|
$ |
1,170 |
|
$ |
1,803 |
|
$ |
(633 |
) |
|
Ag Services |
|
190 |
|
|
107 |
|
|
83 |
|
|
|
462 |
|
|
461 |
|
|
1 |
|
|
Crushing |
|
13 |
|
|
187 |
|
|
(174 |
) |
|
|
93 |
|
|
632 |
|
|
(539 |
) |
|
Refined Products and Other |
|
120 |
|
|
124 |
|
|
(4 |
) |
|
|
410 |
|
|
431 |
|
|
(21 |
) |
|
Wilmar |
|
56 |
|
|
62 |
|
|
(6 |
) |
|
|
205 |
|
|
279 |
|
|
(74 |
) |
|
|
|
|
|
|
|
|
|
||||||||||||
|
Carbohydrate Solutions |
$ |
336 |
|
$ |
452 |
|
$ |
(116 |
) |
|
$ |
912 |
|
$ |
1,057 |
|
$ |
(145 |
) |
|
Starches and Sweeteners |
|
293 |
|
|
455 |
|
|
(162 |
) |
|
|
804 |
|
|
1,039 |
|
|
(235 |
) |
|
|
|
43 |
|
|
(3 |
) |
|
46 |
|
|
|
108 |
|
|
18 |
|
|
90 |
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Nutrition |
$ |
130 |
|
$ |
105 |
|
$ |
25 |
|
|
$ |
340 |
|
$ |
298 |
|
$ |
42 |
|
|
Human Nutrition |
|
96 |
|
|
86 |
|
|
10 |
|
|
|
263 |
|
|
265 |
|
|
(2 |
) |
|
Animal Nutrition |
|
34 |
|
|
19 |
|
|
15 |
|
|
|
77 |
|
|
33 |
|
|
44 |
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Corporate Results |
$ |
(532 |
) |
$ |
(409 |
) |
$ |
(123 |
) |
|
$ |
(1,472 |
) |
$ |
(1,254 |
) |
$ |
(218 |
) |
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest expense - net |
|
(98 |
) |
|
(113 |
) |
|
15 |
|
|
|
(311 |
) |
|
(351 |
) |
|
40 |
|
|
Unallocated corporate function costs |
|
(265 |
) |
|
(306 |
) |
|
41 |
|
|
|
(912 |
) |
|
(903 |
) |
|
(9 |
) |
|
Other income - net |
|
5 |
|
|
10 |
|
|
(5 |
) |
|
|
29 |
|
|
16 |
|
|
13 |
|
|
Specified items: |
|
|
|
|
|
|
|
||||||||||||
|
Expenses related to acquisitions |
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
(4 |
) |
|
4 |
|
|
Revaluation losses, including impairment, and restructuring charges |
|
(174 |
) |
|
— |
|
|
(174 |
) |
|
|
(278 |
) |
|
(12 |
) |
|
(266 |
) |
|
Consolidated Statements of Earnings (unaudited) |
|||||||||||||||
|
|
Quarter ended |
|
Nine months ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
|
(in millions, except per share amounts) |
||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues |
$ |
20,372 |
|
|
$ |
19,937 |
|
|
$ |
61,713 |
|
|
$ |
64,032 |
|
|
Cost of products sold |
|
19,102 |
|
|
|
18,572 |
|
|
|
57,893 |
|
|
|
59,612 |
|
|
Gross Profit |
|
1,270 |
|
|
|
1,365 |
|
|
|
3,820 |
|
|
|
4,420 |
|
|
Selling, general, and administrative expenses |
|
873 |
|
|
|
905 |
|
|
|
2,716 |
|
|
|
2,763 |
|
|
Asset impairment, exit, and restructuring costs |
|
246 |
|
|
|
507 |
|
|
|
421 |
|
|
|
532 |
|
|
Equity in loss (earnings) of unconsolidated affiliates |
|
41 |
|
|
|
(134 |
) |
|
|
(237 |
) |
|
|
(498 |
) |
|
Interest and investment (income) expense |
|
(121 |
) |
|
|
(137 |
) |
|
|
(189 |
) |
|
|
(400 |
) |
|
Interest expense |
|
153 |
|
|
|
174 |
|
|
|
470 |
|
|
|
527 |
|
|
Other (income) - net |
|
(69 |
) |
|
|
(58 |
) |
|
|
(140 |
) |
|
|
(92 |
) |
|
Earnings Before Income Taxes |
|
147 |
|
|
|
108 |
|
|
|
779 |
|
|
|
1,588 |
|
|
Income tax expense |
|
37 |
|
|
|
90 |
|
|
|
160 |
|
|
|
370 |
|
|
Net Earnings Including Non-controlling Interests |
|
110 |
|
|
|
18 |
|
|
|
619 |
|
|
|
1,218 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Less: Net earnings (loss) attributable to non-controlling interests |
|
2 |
|
|
|
— |
|
|
|
(3 |
) |
|
|
(15 |
) |
|
Net Earnings Attributable to |
$ |
108 |
|
|
$ |
18 |
|
|
$ |
622 |
|
|
$ |
1,233 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Diluted earnings per common share |
$ |
0.22 |
|
|
$ |
0.04 |
|
|
$ |
1.29 |
|
|
$ |
2.48 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Average number of diluted shares outstanding |
|
484 |
|
|
|
483 |
|
|
|
484 |
|
|
|
497 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Summary of Financial Condition (unaudited) |
||||||
|
|
|
|
|
|
||
|
|
|
(in millions) |
||||
|
Net Investment In |
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
1,235 |
|
$ |
784 |
|
Operating working capital |
|
|
7,176 |
|
|
9,297 |
|
Property, plant, and equipment |
|
|
11,092 |
|
|
10,828 |
|
Investments in affiliates |
|
|
5,205 |
|
|
5,142 |
|
|
|
|
6,807 |
|
|
6,999 |
|
Other non-current assets |
|
|
2,382 |
|
|
2,604 |
|
|
|
$ |
33,897 |
|
$ |
35,654 |
|
Financed By |
|
|
|
|
||
|
Short-term debt |
|
$ |
246 |
|
$ |
1,733 |
|
Long-term debt, including current maturities |
|
|
7,610 |
|
|
8,303 |
|
Deferred liabilities |
|
|
3,289 |
|
|
3,351 |
|
Temporary equity |
|
|
250 |
|
|
283 |
|
Shareholders’ equity |
|
|
22,502 |
|
|
21,984 |
|
|
|
$ |
33,897 |
|
$ |
35,654 |
|
Summary of Cash Flows (unaudited) |
||||||||
|
|
|
Nine months ended |
||||||
|
|
|
|
||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
(in millions) |
||||||
|
Cash flows from operating activities |
|
|
|
|
||||
|
Net earnings including non-controlling interests |
|
$ |
619 |
|
|
$ |
1,218 |
|
|
Depreciation and amortization |
|
|
874 |
|
|
|
854 |
|
|
Asset impairment charges |
|
|
337 |
|
|
|
517 |
|
|
Loss on asset sales / investment revaluation, net |
|
|
103 |
|
|
|
9 |
|
|
Other – net |
|
|
154 |
|
|
|
(257 |
) |
|
Other changes in operating assets and liabilities |
|
|
3,678 |
|
|
|
127 |
|
|
Net cash provided by operating activities (1) |
|
|
5,765 |
|
|
|
2,468 |
|
|
|
|
|
|
|
||||
|
Cash flows from investing activities |
|
|
|
|
||||
|
Capital expenditures |
|
|
(892 |
) |
|
|
(1,071 |
) |
|
Net assets of businesses acquired |
|
|
(108 |
) |
|
|
(936 |
) |
|
Proceeds from sales of assets |
|
|
78 |
|
|
|
31 |
|
|
Purchases of marketable securities |
|
|
(11 |
) |
|
|
— |
|
|
Proceeds from sales of marketable securities |
|
|
276 |
|
|
|
— |
|
|
Other – net |
|
|
13 |
|
|
|
(26 |
) |
|
Net cash used in investing activities |
|
|
(644 |
) |
|
|
(2,002 |
) |
|
|
|
|
|
|
||||
|
Cash flows from financing activities |
|
|
|
|
||||
|
Long-term debt payments |
|
|
(763 |
) |
|
|
(1 |
) |
|
Net (repayments) borrowings under lines of credit agreements |
|
|
(1,666 |
) |
|
|
1,627 |
|
|
Share repurchases, net of tax |
|
|
— |
|
|
|
(2,327 |
) |
|
Cash dividends |
|
|
(743 |
) |
|
|
(744 |
) |
|
Acquisition of non-controlling interest |
|
|
(4 |
) |
|
|
— |
|
|
Other – net |
|
|
(21 |
) |
|
|
(20 |
) |
|
Net cash used in financing activities |
|
|
(3,197 |
) |
|
|
(1,465 |
) |
|
Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents |
|
|
27 |
|
|
|
6 |
|
|
Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents |
|
|
1,951 |
|
|
|
(993 |
) |
|
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period |
|
|
3,924 |
|
|
|
5,390 |
|
|
Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period |
|
$ |
5,875 |
|
|
$ |
4,397 |
|
|
1 Cash flows from operations before working capital is a Non-GAAP financial measure and is cash flows provided by operating activities of |
||||||||
|
Segment Operating Analysis (unaudited) |
|||||||||||
|
|
Quarter ended |
|
Nine months ended |
||||||||
|
|
|
|
|
||||||||
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
|
(in ‘000s metric tons) |
||||||||||
|
Certain processed volumes (by commodity) |
|
|
|
|
|
|
|
||||
|
Oilseeds |
|
8,803 |
|
|
8,410 |
|
|
26,944 |
|
|
26,669 |
|
Corn |
|
4,666 |
|
|
4,943 |
|
|
13,861 |
|
|
13,833 |
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||
|
|
Quarter ended |
|
Nine months ended |
||||||||
|
|
|
|
|
||||||||
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
|
(in millions) |
||||||||||
|
Revenues |
|
|
|
|
|
|
|
||||
|
Ag Services and Oilseeds |
$ |
15,613 |
|
$ |
15,089 |
|
$ |
47,557 |
|
$ |
49,642 |
|
Carbohydrate Solutions |
|
2,734 |
|
|
2,908 |
|
|
8,096 |
|
|
8,484 |
|
Nutrition |
|
1,916 |
|
|
1,831 |
|
|
5,726 |
|
|
5,575 |
|
Total Segment Revenues |
|
20,263 |
|
|
19,828 |
|
|
61,379 |
|
|
63,701 |
|
Other Business |
|
109 |
|
|
109 |
|
|
334 |
|
|
331 |
|
Total Revenues |
$ |
20,372 |
|
$ |
19,937 |
|
$ |
61,713 |
|
$ |
64,032 |
|
Total Segment Operating Profit A Non-GAAP financial measure (unaudited) |
|||||||||||||||||||
|
|
Quarter ended |
|
|
Nine months ended |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
(In millions) |
|
2025 |
|
|
2024 |
|
Change |
|
|
2025 |
|
|
2024 |
|
Change |
||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Earnings before income taxes |
$ |
147 |
|
$ |
108 |
|
$ |
39 |
|
|
$ |
779 |
|
$ |
1,588 |
|
$ |
(809 |
) |
|
Other Business (earnings) loss |
|
(55 |
) |
|
17 |
|
|
(72 |
) |
|
|
(245 |
) |
|
(200 |
) |
|
(45 |
) |
|
Corporate |
|
532 |
|
|
409 |
|
|
123 |
|
|
|
1,472 |
|
|
1,254 |
|
|
218 |
|
|
Specified items: |
|
|
|
|
|
|
|
||||||||||||
|
(Gain) on sales of assets and businesses |
|
(31 |
) |
|
(1 |
) |
|
(30 |
) |
|
|
(39 |
) |
|
(1 |
) |
|
(38 |
) |
|
Impairment, exit, restructuring charges, and settlement contingencies |
|
89 |
|
|
504 |
|
|
(415 |
) |
|
|
361 |
|
|
517 |
|
|
(156 |
) |
|
(Gain) on contract termination |
|
— |
|
|
— |
|
|
— |
|
|
|
(69 |
) |
|
— |
|
|
(69 |
) |
|
|
$ |
163 |
|
$ |
— |
|
$ |
163 |
|
|
$ |
163 |
|
$ |
— |
|
$ |
163 |
|
|
Total Segment Operating Profit |
$ |
845 |
|
$ |
1,037 |
|
$ |
(192 |
) |
|
$ |
2,422 |
|
$ |
3,158 |
|
$ |
(736 |
) |
|
Adjusted Net Earnings and Adjusted EPS Non-GAAP financial measures (unaudited) |
|||||||||||||||||||||||
|
|
Quarter ended |
|
Nine months ended |
||||||||||||||||||||
|
|
2025 |
2024 |
|
2025 |
2024 |
||||||||||||||||||
|
|
In
|
Per
|
In
|
Per
|
|
In
|
Per
|
In
|
Per
|
||||||||||||||
|
Net earnings and reported EPS (diluted) |
$ |
108 |
|
$ |
0.22 |
|
$ |
18 |
|
$ |
0.04 |
|
$ |
622 |
|
$ |
1.29 |
|
$ |
1,233 |
|
$ |
2.48 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
||||||||||||||
|
(Gain) on sales of assets and businesses (a) |
|
(24 |
) |
|
(0.05 |
) |
|
(1 |
) |
|
— |
|
|
(30 |
) |
|
(0.06 |
) |
|
(1 |
) |
|
— |
|
Impairment, exit, restructuring charges, and settlement contingencies (b) |
|
201 |
|
|
0.41 |
|
|
500 |
|
|
1.03 |
|
|
535 |
|
|
1.10 |
|
|
523 |
|
|
1.06 |
|
|
|
163 |
|
|
0.34 |
|
|
— |
|
|
— |
|
|
163 |
|
|
0.34 |
|
|
— |
|
|
— |
|
Expenses related to acquisitions (d) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
3 |
|
|
0.01 |
|
(Gain) on contract termination (e) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(52 |
) |
|
(0.11 |
) |
|
— |
|
|
— |
|
Certain discrete tax adjustments (f) |
|
— |
|
|
— |
|
|
13 |
|
|
0.02 |
|
|
— |
|
|
— |
|
|
30 |
|
|
0.06 |
|
Total adjustments |
|
340 |
|
|
0.70 |
|
|
512 |
|
|
1.05 |
|
|
616 |
|
|
1.27 |
|
|
555 |
|
|
1.13 |
|
Adjusted net earnings and adjusted diluted EPS |
$ |
448 |
|
$ |
0.92 |
|
$ |
530 |
|
$ |
1.09 |
|
$ |
1,238 |
|
$ |
2.56 |
|
$ |
1,788 |
|
$ |
3.61 |
| (a) |
Current quarter and YTD amounts of |
|
| (b) |
Current quarter and YTD charges of |
|
| (c) |
Current quarter and YTD charges of |
|
| (d) |
Prior YTD charges of |
|
| (e) |
Current YTD gains of |
|
| (f) |
Tax expense adjustment due to certain discrete items totaling |
|
Return on Non-GAAP financial measures (unaudited) |
|||||||||||||||||||
|
Adjusted ROIC Earnings (in millions) |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
Four Quarters |
|||||||||||
|
|
Quarter Ended |
|
Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net earnings attributable to |
$ |
567 |
|
|
$ |
295 |
|
|
$ |
219 |
|
|
$ |
108 |
|
|
$ |
1,189 |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
||||||||||
|
Interest expense(1) |
|
132 |
|
|
|
116 |
|
|
|
116 |
|
|
|
106 |
|
|
|
470 |
|
|
Tax on interest |
|
(36 |
) |
|
|
(28 |
) |
|
|
(28 |
) |
|
|
(25 |
) |
|
|
(117 |
) |
|
Total ROIC Earnings |
|
663 |
|
|
|
383 |
|
|
|
307 |
|
|
|
189 |
|
|
|
1,542 |
|
|
Other adjustments, net of tax |
|
(22 |
) |
|
|
43 |
|
|
|
233 |
|
|
|
341 |
|
|
|
595 |
|
|
Total Adjusted ROIC Earnings |
$ |
641 |
|
|
$ |
426 |
|
|
$ |
540 |
|
|
$ |
530 |
|
|
$ |
2,137 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Quarter Ended |
|
Trailing Four |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
Quarter Average |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Equity(2) |
$ |
22,168 |
|
|
$ |
22,119 |
|
$ |
22,430 |
|
$ |
22,494 |
|
$ |
22,303 |
|
|
Interest-bearing liabilities(3) |
|
10,180 |
|
|
|
11,088 |
|
|
9,252 |
|
|
7,956 |
|
|
9,619 |
|
|
|
|
32,348 |
|
|
|
33,207 |
|
|
31,682 |
|
|
30,450 |
|
|
31,922 |
|
|
Other adjustments, net of tax |
|
(22 |
) |
|
|
43 |
|
|
233 |
|
|
341 |
|
|
149 |
|
|
|
$ |
32,326 |
|
|
$ |
33,250 |
|
$ |
31,915 |
|
$ |
30,791 |
|
$ |
32,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Return on |
|
|
|
|
|
|
|
|
4.8 |
% |
||||||
|
Adjusted Return on |
|
|
|
|
|
|
|
|
6.7 |
% |
||||||
|
(1) Represents interest expense on borrowings and therefore excludes (2) Excludes non-controlling interests (3) Includes short-term debt, long term debt and finance lease obligations |
||||||||||||||||
|
Earnings Before Interest, Taxes, and Depreciation and Amortization (EBITDA) and Adjusted EBITDA Non-GAAP financial measures (unaudited) |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
Four Quarters |
|
Four Quarters |
||||||||||||
|
|
Quarter Ended |
|
Ended |
|
Ended |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
(in millions) |
|
|
|
|
|
|
||||||||||||
|
Net earnings |
$ |
567 |
|
|
$ |
295 |
|
|
$ |
219 |
|
|
$ |
108 |
|
|
$ |
1,189 |
|
|
$ |
1,798 |
|
|
Net (loss) earnings attributable to non-controlling interests |
|
(6 |
) |
|
|
(3 |
) |
|
|
(2 |
) |
|
|
2 |
|
|
|
(9 |
) |
|
|
(38 |
) |
|
Income tax expense |
|
106 |
|
|
|
61 |
|
|
|
62 |
|
|
|
37 |
|
|
|
266 |
|
|
|
563 |
|
|
Interest expense(1) |
|
132 |
|
|
|
116 |
|
|
|
116 |
|
|
|
106 |
|
|
|
470 |
|
|
|
483 |
|
|
Depreciation and amortization(2) |
|
287 |
|
|
|
284 |
|
|
|
286 |
|
|
|
295 |
|
|
|
1,152 |
|
|
|
1,131 |
|
|
EBITDA |
|
1,086 |
|
|
|
753 |
|
|
|
681 |
|
|
|
548 |
|
|
|
3,068 |
|
|
|
3,937 |
|
|
(Gain) on sales of assets and businesses |
|
(10 |
) |
|
|
— |
|
|
|
(8 |
) |
|
|
(31 |
) |
|
|
(49 |
) |
|
|
(8 |
) |
|
Impairment, exit, restructuring charges, and settlement contingencies |
|
(16 |
) |
|
|
54 |
|
|
|
323 |
|
|
|
261 |
|
|
|
622 |
|
|
|
701 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
163 |
|
|
|
163 |
|
|
|
||
|
(Gain) on contract termination |
|
— |
|
|
|
— |
|
|
|
(69 |
) |
|
|
— |
|
|
|
(69 |
) |
|
|
— |
|
|
Expenses related to acquisitions |
|
3 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3 |
|
|
|
5 |
|
|
Railroad maintenance expense |
|
32 |
|
|
|
— |
|
|
|
4 |
|
|
|
12 |
|
|
|
48 |
|
|
|
71 |
|
|
Adjusted EBITDA |
$ |
1,095 |
|
|
$ |
807 |
|
|
$ |
931 |
|
|
$ |
954 |
|
|
$ |
3,787 |
|
|
$ |
4,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
(1) Represents interest expense on borrowings and therefore excludes
(2) Excludes |
|||||||||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20251104196146/en/
Media Contact
media@adm.com
Investor Relations
Kathryn.Walsh@adm.com
Source: